Asymmetric Hypertrophic Cardiomyopathy in Athletes: Always a Higher Risk for Sudden Death?
Keywords:
Sudden death, Athlete heart, Hypertrophic cardiomyopathyAbstract
Hypertrophic cardiomyopathy (HCM) may be associated with considerable mortality in athletes. However, differentiating myocardial hypertrophy as a physiological adaptation of the heart to exercise can be a clinical challenge. In this context, nuclear magnetic resonance imaging has been shown to be a essential exam for diagnostic elucidation. The case report aimed to depict a young athlete with syncope and an initial investigation suggestive of HCM, which was excluded after deconditioning and serial MRI.
Downloads
References
- Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006. Circulation 2009;119:1085-1092.
- O’Mahony C, Jichi F, Pavlou M, Monserrat L, Anstasakis A, Rapezzi C, et al. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD). Eur Heart J 2014;35:2010–2020.
- Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation 1995;92:785-789.
- Steriotis AK, Sharma S. Risk Stratification in Hypertrophic Cardiomyopathy. Eur Cardiol 2015;10:31-36.
- Maron BJ, Seidman JG, Seidman CE. Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy 2004;44:2125-2132.
- Maron BJ. Sudden Death in Young Athletes. N Engl J Med 2003;349:1064-1075.
- Gati S, Sharma S, Pennell D. The Role of Cardiovascular Magnetic Resonance Imaging in the Assessment of Highly Trained Athletes. JACC Cardiovasc Imaging 2018;11:247-259.
- Brosnan MJ, Rakhit D. Differentiating Athlete’s Heart From Cardiomyopathies – The Left Side. Heart Lung Circ 2018;27:1052-1062.